Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression
Clinical Study of Atlanto-occipital Decompression Lateral Joint Release Combined With Occipital-neck Fusion in the Treatment of Chiari Malformation Combined With Type II Skull Base Depression
1 other identifier
interventional
64
1 country
1
Brief Summary
The research background of this study is that Chiari malformation (CM) is a congenital malformation in the foramen magnum region, often associated with syringomyelia, basilar depression, odontoid dislocation and other craniocervical junction deformities. The traditional surgical method for Chiari malformation with skull basilar depression is simple decompression without fixation, so it cannot effectively maintain the stability of the cervical spine and reduce the compression of the brainstem and cervical cord, often resulting in poor curative effect and aggravated symptoms. The cervical spine is the most flexible and most mobile part of the spine, and the instability of the cervical spine will directly affect the quality of life of patients after surgery. Subsequently, with the continuous advancement of technology and the continuous development and improvement of surgical methods, Investigators can relieve spinal cord compression by using atlanto-occipital decompression and dissection followed by C1/2 lateral arthrolysis combined with occipitocervical fusion. So, is this surgical combination the most effective surgery for patients with Chiari malformation and type II skull basilar depression? How should doctors adjust to the best surgical approach to treat patients with Chiari malformation and type II skull basilar depression? These questions have long puzzled neurosurgeons. By conducting this research, investigators hope that participants can participate in it, and work with them to answer this question, and jointly promote the development and progress of doctors' careers, while benefiting more patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2023
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2024
CompletedApril 28, 2026
April 1, 2026
1.8 years
January 28, 2023
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Chang of Chicago Chiari outcome score
The Chicago Chiari Malformation Prognosis Scale (CCOS) is a comprehensive quantitative scoring criterion for surgical prognosis in patients with Chiari malformations, first proposed by the Department of Neurosurgery of the University of Chicago School of Medicine. CCOS covered four scoring criteria, including improvement in pain symptoms, improvement in non-pain symptoms, ability to live, and surgery-related complications, with a single score of 1-4 for a total score of 4 to 16, and at the last follow-up, the higher the patient's score indicated the better the patient's postoperative prognosis.
through study completion, an average of 1 year
Secondary Outcomes (5)
Occurrence of complications
The second week after surgery
Chang of Magnetic Resonance Imaging
through study completion, an average of 1 year
Chang of Visual Analog Score for pain
through study completion, an average of 1 year
Chang of Japanese Orthopaedic Association Scores
through study completion, an average of 1 year
Chang of Neck Disability Index
through study completion, an average of 1 year
Study Arms (2)
Experimental: FMD + C1/2 Facet Release + OCF
EXPERIMENTALAll patients underwent preoperative dynamic CT scans in flexion, neutral, and extension positions, and all were treated surgically with atlanto-occipital decompression, CI/2 lateral articular release, combined with occipital-cervical fusion.
Active Comparator: Simple FMD + Outer Dural Delamination
ACTIVE COMPARATORPatients in this arm will receive the traditional standard procedure, which consists of simple bony foramen magnum decompression combined with outer dural delamination (without opening the inner layer of the dura mater to reduce complications).
Interventions
A. Chiari malformation combined with type II Basilar invagination showed that the slope spinal canal angle decreased, and the position of the dentition moved up. The yellow fusion device in the picture is C1/2 lateral inter-articular Cage (the patent granted by the applicant for this project); B. After atlanto-occipital decompression, C1/2 lateral inter-articular release is performed, and a fusion device is implanted to move down the position of the tip of the tooth process to reduce the compression of the cervical medulla oblongata; C. Implantation of the posterior neck nail rod system; D. Improve the angle of the sloped spinal canal by posterior compression rod technique (Cantilever) to further reduce the compression on the superior cervical medulla oblongata.
This arm utilizes the traditional standard strategy, distinct from the comprehensive fusion in the experimental arm. The specific distinguishing details are: Performing strictly anatomical decompression ONLY. This involves bony foramen magnum decompression combined with outer dural delamination (without opening the inner layer of the dura mater). This arm specifically EXCLUDES C1/2 facet joint release, cage implantation, and any form of occipitocervical internal fixation or biomechanical reconstruction.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Chiari malformation
- Combined with type II skull base depression
- Clinical symptoms related to the disease
- Complete clinical imaging data
- Must be the first surgery
You may not qualify if:
- Secondary cerebellar tonsillar hernia
- Severe atlantoaxial dislocation
- Osteochondroplastica
- Rheumatoid arthritis
- Down syndrome
- Refurbished case reoperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nan fang hospital, Southern medical university
Guangzhou, Guangdong, 510515, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
yutao lu
2Nanfang Neurology Research Institution, Nanfang Hospital, Southern Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 28, 2023
First Posted
March 6, 2023
Study Start
March 1, 2023
Primary Completion
December 12, 2024
Study Completion
December 16, 2024
Last Updated
April 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share